(Q43215888)

16 November 2017

0 references

The additional facet of immunoscore: immunoprofiling as a possible predictive tool for cancer treatment (English)

1 reference

16 November 2017

2

1 reference

16 November 2017

8

1 reference

16 November 2017

9

Jérôme Galon

0 references

Gerardo Botti

series ordinal

5

object named as

Gerardo Botti

1 reference

16 November 2017

Paolo Antonio Ascierto

series ordinal

1

object named as

Paolo A Ascierto

1 reference

16 November 2017

7

Francesco M Marincola

1 reference

16 November 2017

10

Bernard A Fox

1 reference

16 November 2017

4

Carlo B Bifulco

1 reference

16 November 2017

6

Alessandro Lugli

1 reference

16 November 2017

3

Walter J Urba

1 reference

16 November 2017

language of work or name

1 reference

3 March 2013

1 reference

Journal of Translational Medicine

16 November 2017

1 reference

16 November 2017

11

1 reference

16 November 2017

54

1 reference

Creative Commons Attribution 2.0 Generic

16 November 2017

start time

3 March 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

1 reference

April 2022 Public Data File from Crossref

exact match

https://scigraph.springernature.com/pub.10.1186/1479-5876-11-54

0 references

cites work

Impact of CD68/(CD3+CD20) ratio at the invasive front of primary tumors on distant metastasis development in breast cancer

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3608225

12-Chemokine gene signature identifies lymph node-like structures in melanoma: potential for patient selection for immunotherapy?

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3608225

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3608225

The immune contexture in human tumours: impact on clinical outcome

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3608225

A prospective phase II trial exploring the association between tumor microenvironment biomarkers and clinical activity of ipilimumab in advanced melanoma.

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3608225

Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3608225

Science gone translational: the OX40 agonist story

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3608225

Unique ectopic lymph node-like structures present in human primary colorectal carcinoma are identified by immune gene array profiling

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3608225

Clinical development of mAbs to block the PD1 pathway as an immunotherapy for cancer.

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3608225

Clinical experiences with anti-CD137 and anti-PD1 therapeutic antibodies

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3608225

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3608225

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3608225

Immunosuppression by melanoma cells as a factor in the generation of metastatic disease

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3608225

Biomarkers for immunostimulatory monoclonal antibodies in combination strategies for melanoma and other tumor types

25 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3608225

The immune score as a new possible approach for the classification of cancer

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3608225

Histopathologic-based prognostic factors of colorectal cancers are associated with the state of the local immune reaction.

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3608225

In situ cytotoxic and memory T cells predict outcome in patients with early-stage colorectal cancer.

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3608225

Sentinel lymph nodes show profound downregulation of antigen-presenting cells of the paracortex: implications for tumor biology and treatment

15 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3608225

15 August 2018

Identifiers

DOI

10.1186/1479-5876-11-54

1 reference

Dimensions Publication ID

16 November 2017

0 references

1 reference

16 November 2017

1 reference